0.008797
0.000000
0.000456
0.000000
0.014426
0.000000
0.000000
0.000000
0.023633
0.00000
0.00000
0.00000
Griessner, A.
Brandstetter, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
92.97
90.00
113.670
69.320
42.370
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C4 H9 N O2
103.120
n
ALPHA-AMINOISOBUTYRIC ACID
L-peptide linking
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C3 H8 O3
92.094
GLYCEROL
GLYCERIN; PROPANE-1,2,3-TRIOL
non-polymer
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
289
1732
10.1074/JBC.M113.533836
24275667
Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor Viia by Tissue Factor Pathway Inhibitor (Tfpi)
2014
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
SINGLE WAVELENGTH
M
x-ray
1
0.97
1.0
X12
EMBL/DESY, HAMBURG
0.97
SYNCHROTRON
EMBL/DESY, HAMBURG BEAMLINE X12
9278.473
TISSUE FACTOR PATHWAY INHIBITOR (LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR) VARIANT
RESIDUES 40-118
2
nat
polymer
2363.712
PEPTIDE
2
syn
polymer
92.094
GLYCEROL
2
syn
non-polymer
18.015
water
72
nat
water
no
no
DSEEDEEHTIITDTELPPLKLMHSFCAFKADDGPCKAIMKRFFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRD
DSEEDEEHTIITDTELPPLKLMHSFCAFKADDGPCKAIMKRFFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRD
A,B
polypeptide(L)
no
yes
(ACE)FQSKPNVHVDGYFERL(AIB)AKL
XFQSKPNVHVDGYFERLAAKL
C,D
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
HOMO SAPIENS
3.58
65.68
NONE
diffrn_source
pdbx_unobs_or_zero_occ_residues
struct_conn
repository
Initial release
Database references
Database references
Database references
Advisory
Data collection
Derived calculations
1
0
2013-12-04
1
1
2013-12-11
1
2
2014-02-05
1
3
2015-03-25
1
4
2019-07-17
_diffrn_source.pdbx_synchrotron_site
_struct_conn.pdbx_leaving_atom_flag
PDBE
Y
PDBE
2013-05-30
REL
1
A
O
HOH
2006
5.95
1
B
O
HOH
2026
7.23
GOL
GLYCEROL
HOH
water
32630
SYNTHETIC CONSTRUCT
sample
GOL
1080
3
GOL
GOL
1080
B
GOL
1081
3
GOL
GOL
1081
B
HOH
2001
4
HOH
HOH
2001
A
HOH
2002
4
HOH
HOH
2002
A
HOH
2003
4
HOH
HOH
2003
A
HOH
2004
4
HOH
HOH
2004
A
HOH
2005
4
HOH
HOH
2005
A
HOH
2006
4
HOH
HOH
2006
A
HOH
2007
4
HOH
HOH
2007
A
HOH
2008
4
HOH
HOH
2008
A
HOH
2009
4
HOH
HOH
2009
A
HOH
2010
4
HOH
HOH
2010
A
HOH
2011
4
HOH
HOH
2011
A
HOH
2012
4
HOH
HOH
2012
A
HOH
2013
4
HOH
HOH
2013
A
HOH
2014
4
HOH
HOH
2014
A
HOH
2015
4
HOH
HOH
2015
A
HOH
2016
4
HOH
HOH
2016
A
HOH
2017
4
HOH
HOH
2017
A
HOH
2018
4
HOH
HOH
2018
A
HOH
2019
4
HOH
HOH
2019
A
HOH
2020
4
HOH
HOH
2020
A
HOH
2021
4
HOH
HOH
2021
A
HOH
2022
4
HOH
HOH
2022
A
HOH
2023
4
HOH
HOH
2023
A
HOH
2024
4
HOH
HOH
2024
A
HOH
2025
4
HOH
HOH
2025
A
HOH
2026
4
HOH
HOH
2026
A
HOH
2027
4
HOH
HOH
2027
A
HOH
2028
4
HOH
HOH
2028
A
HOH
2029
4
HOH
HOH
2029
A
HOH
2030
4
HOH
HOH
2030
A
HOH
2031
4
HOH
HOH
2031
A
HOH
2032
4
HOH
HOH
2032
A
HOH
2033
4
HOH
HOH
2033
A
HOH
2001
4
HOH
HOH
2001
B
HOH
2002
4
HOH
HOH
2002
B
HOH
2003
4
HOH
HOH
2003
B
HOH
2004
4
HOH
HOH
2004
B
HOH
2005
4
HOH
HOH
2005
B
HOH
2006
4
HOH
HOH
2006
B
HOH
2007
4
HOH
HOH
2007
B
HOH
2008
4
HOH
HOH
2008
B
HOH
2009
4
HOH
HOH
2009
B
HOH
2010
4
HOH
HOH
2010
B
HOH
2011
4
HOH
HOH
2011
B
HOH
2012
4
HOH
HOH
2012
B
HOH
2013
4
HOH
HOH
2013
B
HOH
2014
4
HOH
HOH
2014
B
HOH
2015
4
HOH
HOH
2015
B
HOH
2016
4
HOH
HOH
2016
B
HOH
2017
4
HOH
HOH
2017
B
HOH
2018
4
HOH
HOH
2018
B
HOH
2019
4
HOH
HOH
2019
B
HOH
2020
4
HOH
HOH
2020
B
HOH
2021
4
HOH
HOH
2021
B
HOH
2022
4
HOH
HOH
2022
B
HOH
2023
4
HOH
HOH
2023
B
HOH
2024
4
HOH
HOH
2024
B
HOH
2025
4
HOH
HOH
2025
B
HOH
2026
4
HOH
HOH
2026
B
HOH
2001
4
HOH
HOH
2001
C
HOH
2002
4
HOH
HOH
2002
C
HOH
2003
4
HOH
HOH
2003
C
HOH
2004
4
HOH
HOH
2004
C
HOH
2005
4
HOH
HOH
2005
C
HOH
2006
4
HOH
HOH
2006
C
HOH
2007
4
HOH
HOH
2007
C
HOH
2008
4
HOH
HOH
2008
C
HOH
2001
4
HOH
HOH
2001
D
HOH
2002
4
HOH
HOH
2002
D
HOH
2003
4
HOH
HOH
2003
D
HOH
2004
4
HOH
HOH
2004
D
HOH
2005
4
HOH
HOH
2005
D
n
1
1
A
SER
2
n
2
SER
2
A
GLU
3
n
3
GLU
3
A
GLU
4
n
4
GLU
4
A
ASP
5
n
5
ASP
5
A
GLU
6
n
6
GLU
6
A
GLU
7
n
7
GLU
7
A
HIS
8
n
8
HIS
8
A
THR
9
n
9
THR
9
A
ILE
10
n
10
ILE
10
A
ILE
11
n
11
ILE
11
A
THR
12
n
12
THR
12
A
ASP
13
n
13
ASP
13
A
THR
14
n
14
THR
14
A
GLU
15
n
15
GLU
15
A
LEU
16
n
16
LEU
16
A
PRO
17
n
17
PRO
17
A
PRO
18
n
18
PRO
18
A
LEU
19
n
19
LEU
19
A
LYS
20
n
20
LYS
20
A
LEU
21
n
21
LEU
21
A
MET
22
n
22
MET
22
A
HIS
23
n
23
HIS
23
A
SER
24
n
24
SER
24
A
PHE
25
n
25
PHE
25
A
CYS
26
n
26
CYS
26
A
ALA
27
n
27
ALA
27
A
PHE
28
n
28
PHE
28
A
LYS
29
n
29
LYS
29
A
ALA
30
n
30
ALA
30
A
ASP
31
n
31
ASP
31
A
ASP
32
n
32
ASP
32
A
GLY
33
n
33
GLY
33
A
PRO
34
n
34
PRO
34
A
CYS
35
n
35
CYS
35
A
LYS
36
n
36
LYS
36
A
ALA
37
n
37
ALA
37
A
ILE
38
n
38
ILE
38
A
MET
39
n
39
MET
39
A
LYS
40
n
40
LYS
40
A
ARG
41
n
41
ARG
41
A
PHE
42
n
42
PHE
42
A
PHE
43
n
43
PHE
43
A
PHE
44
n
44
PHE
44
A
ASN
45
n
45
ASN
45
A
ILE
46
n
46
ILE
46
A
PHE
47
n
47
PHE
47
A
THR
48
n
48
THR
48
A
ARG
49
n
49
ARG
49
A
GLN
50
n
50
GLN
50
A
CYS
51
n
51
CYS
51
A
GLU
52
n
52
GLU
52
A
GLU
53
n
53
GLU
53
A
PHE
54
n
54
PHE
54
A
ILE
55
n
55
ILE
55
A
TYR
56
n
56
TYR
56
A
GLY
57
n
57
GLY
57
A
GLY
58
n
58
GLY
58
A
CYS
59
n
59
CYS
59
A
GLU
60
n
60
GLU
60
A
GLY
61
n
61
GLY
61
A
ASN
62
n
62
ASN
62
A
GLN
63
n
63
GLN
63
A
ASN
64
n
64
ASN
64
A
ARG
65
n
65
ARG
65
A
PHE
66
n
66
PHE
66
A
GLU
67
n
67
GLU
67
A
SER
68
n
68
SER
68
A
LEU
69
n
69
LEU
69
A
GLU
70
n
70
GLU
70
A
GLU
71
n
71
GLU
71
A
CYS
72
n
72
CYS
72
A
LYS
73
n
73
LYS
73
A
LYS
74
n
74
LYS
74
A
MET
75
n
75
MET
75
A
CYS
76
n
76
CYS
76
A
THR
77
n
77
THR
77
A
ARG
78
n
78
ARG
78
A
ASP
79
n
79
ASP
79
A
n
1
1
B
n
2
2
B
n
3
3
B
n
4
4
B
n
5
5
B
n
6
6
B
n
7
7
B
n
8
8
B
n
9
9
B
n
10
10
B
n
11
11
B
n
12
12
B
n
13
13
B
n
14
14
B
GLU
15
n
15
GLU
15
B
LEU
16
n
16
LEU
16
B
PRO
17
n
17
PRO
17
B
PRO
18
n
18
PRO
18
B
LEU
19
n
19
LEU
19
B
LYS
20
n
20
LYS
20
B
LEU
21
n
21
LEU
21
B
MET
22
n
22
MET
22
B
HIS
23
n
23
HIS
23
B
SER
24
n
24
SER
24
B
PHE
25
n
25
PHE
25
B
CYS
26
n
26
CYS
26
B
ALA
27
n
27
ALA
27
B
PHE
28
n
28
PHE
28
B
LYS
29
n
29
LYS
29
B
ALA
30
n
30
ALA
30
B
ASP
31
n
31
ASP
31
B
ASP
32
n
32
ASP
32
B
GLY
33
n
33
GLY
33
B
PRO
34
n
34
PRO
34
B
CYS
35
n
35
CYS
35
B
LYS
36
n
36
LYS
36
B
ALA
37
n
37
ALA
37
B
ILE
38
n
38
ILE
38
B
MET
39
n
39
MET
39
B
LYS
40
n
40
LYS
40
B
ARG
41
n
41
ARG
41
B
PHE
42
n
42
PHE
42
B
PHE
43
n
43
PHE
43
B
PHE
44
n
44
PHE
44
B
ASN
45
n
45
ASN
45
B
ILE
46
n
46
ILE
46
B
PHE
47
n
47
PHE
47
B
THR
48
n
48
THR
48
B
ARG
49
n
49
ARG
49
B
GLN
50
n
50
GLN
50
B
CYS
51
n
51
CYS
51
B
GLU
52
n
52
GLU
52
B
GLU
53
n
53
GLU
53
B
PHE
54
n
54
PHE
54
B
ILE
55
n
55
ILE
55
B
TYR
56
n
56
TYR
56
B
GLY
57
n
57
GLY
57
B
GLY
58
n
58
GLY
58
B
CYS
59
n
59
CYS
59
B
GLU
60
n
60
GLU
60
B
GLY
61
n
61
GLY
61
B
ASN
62
n
62
ASN
62
B
GLN
63
n
63
GLN
63
B
ASN
64
n
64
ASN
64
B
ARG
65
n
65
ARG
65
B
PHE
66
n
66
PHE
66
B
GLU
67
n
67
GLU
67
B
SER
68
n
68
SER
68
B
LEU
69
n
69
LEU
69
B
GLU
70
n
70
GLU
70
B
GLU
71
n
71
GLU
71
B
CYS
72
n
72
CYS
72
B
LYS
73
n
73
LYS
73
B
LYS
74
n
74
LYS
74
B
MET
75
n
75
MET
75
B
CYS
76
n
76
CYS
76
B
THR
77
n
77
THR
77
B
ARG
78
n
78
ARG
78
B
ASP
79
n
79
ASP
79
B
ACE
0
n
1
ACE
0
C
PHE
1
n
2
PHE
1
C
GLN
2
n
3
GLN
2
C
SER
3
n
4
SER
3
C
LYS
4
n
5
LYS
4
C
PRO
5
n
6
PRO
5
C
ASN
6
n
7
ASN
6
C
VAL
7
n
8
VAL
7
C
HIS
8
n
9
HIS
8
C
VAL
9
n
10
VAL
9
C
ASP
10
n
11
ASP
10
C
GLY
11
n
12
GLY
11
C
TYR
12
n
13
TYR
12
C
PHE
13
n
14
PHE
13
C
GLU
14
n
15
GLU
14
C
ARG
15
n
16
ARG
15
C
LEU
16
n
17
LEU
16
C
AIB
17
n
18
AIB
17
C
ALA
18
n
19
ALA
18
C
LYS
19
n
20
LYS
19
C
LEU
20
n
21
LEU
20
C
ACE
0
n
1
ACE
0
D
PHE
1
n
2
PHE
1
D
GLN
2
n
3
GLN
2
D
SER
3
n
4
SER
3
D
LYS
4
n
5
LYS
4
D
PRO
5
n
6
PRO
5
D
ASN
6
n
7
ASN
6
D
VAL
7
n
8
VAL
7
D
HIS
8
n
9
HIS
8
D
VAL
9
n
10
VAL
9
D
ASP
10
n
11
ASP
10
D
GLY
11
n
12
GLY
11
D
TYR
12
n
13
TYR
12
D
PHE
13
n
14
PHE
13
D
GLU
14
n
15
GLU
14
D
ARG
15
n
16
ARG
15
D
LEU
16
n
17
LEU
16
D
AIB
17
n
18
AIB
17
D
ALA
18
n
19
ALA
18
D
LYS
19
n
20
LYS
19
D
LEU
20
n
21
LEU
20
D
6.0311
-2.5206
2.3228
6.0316
-1.8818
4.7404
-0.2079
-0.1771
0.8764
0.0217
0.0096
-0.0810
-0.8999
-0.5480
0.1983
0.2262
0.1323
0.0422
0.1216
-0.0305
0.3969
refined
-13.6806
-16.2708
9.9339
X-RAY DIFFRACTION
7.0881
-3.5234
1.1493
7.6496
-0.8403
4.8966
0.0695
-0.1288
-0.7769
-0.0641
0.1257
0.2331
0.8170
0.4608
-0.1953
0.1657
0.0966
0.0243
0.1124
0.0010
0.2601
refined
14.8306
-41.8889
4.6813
X-RAY DIFFRACTION
0.1600
-0.1140
1.0876
2.0262
-1.8376
8.3060
-0.0279
-0.2095
-0.0183
0.1261
0.2971
0.3653
-0.3724
-1.3738
-0.2692
0.1363
0.0205
0.0423
0.3466
0.0239
0.4034
refined
-15.6987
-25.4721
18.4789
X-RAY DIFFRACTION
12.9509
-8.6428
-2.9321
10.4820
1.0800
0.8376
-0.2456
-0.5212
0.3030
0.4955
0.3052
-0.2255
0.0036
0.1765
-0.0595
0.0928
0.0666
-0.0012
0.2692
-0.0251
0.1788
refined
15.8854
-32.0454
12.2564
X-RAY DIFFRACTION
A
2
A
79
X-RAY DIFFRACTION
1
B
15
B
79
X-RAY DIFFRACTION
2
C
0
C
20
X-RAY DIFFRACTION
3
D
0
D
20
X-RAY DIFFRACTION
4
author_and_software_defined_assembly
PISA
2
dimeric
author_and_software_defined_assembly
PISA
2
dimeric
1920
-10.5
6190
2240
-10.2
5590
C
AIB
17
ALPHA-AMINOISOBUTYRIC ACID
C
AIB
18
ALA
D
AIB
17
ALPHA-AMINOISOBUTYRIC ACID
D
AIB
18
ALA
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
10
A
N
ILE
10
A
O
GLU
4
A
O
GLU
4
A
N
ASP
5
A
N
ASP
5
A
O
LEU
19
A
O
LEU
19
A
N
ASN
45
A
N
ASN
45
A
O
GLN
50
A
O
GLN
50
B
N
ASN
45
B
N
ASN
45
B
O
GLN
50
B
O
GLN
50
1
A
HOH
2006
G
HOH
1
C
HOH
2008
I
HOH
1
A
ASP
1
A
ASP
1
1
Y
1
B
ASP
1
B
ASP
1
1
Y
1
B
SER
2
B
SER
2
1
Y
1
B
GLU
3
B
GLU
3
1
Y
1
B
GLU
4
B
GLU
4
1
Y
1
B
ASP
5
B
ASP
5
1
Y
1
B
GLU
6
B
GLU
6
1
Y
1
B
GLU
7
B
GLU
7
1
Y
1
B
HIS
8
B
HIS
8
1
Y
1
B
THR
9
B
THR
9
1
Y
1
B
ILE
10
B
ILE
10
1
Y
1
B
ILE
11
B
ILE
11
1
Y
1
B
THR
12
B
THR
12
1
Y
1
B
ASP
13
B
ASP
13
1
Y
1
B
THR
14
B
THR
14
1
Y
1
C
CA
PRO
5
WRONG HAND
1
D
CA
PRO
5
WRONG HAND
1
B
B
O
CA
ARG
ASP
78
79
0.90
1
B
B
O
N
ARG
ASP
78
79
0.93
1
B
B
C
CA
ARG
ASP
78
79
1.49
1
A
A
CA
N
ARG
ASP
78
79
1.56
1
B
B
CA
N
ARG
ASP
78
79
1.66
1
A
A
N
O
SER
THR
2
14
1.74
1
A
A
O
O
GLU
HOH
7
2003
2.18
1
A
ARG
78
20.47
1
B
ARG
78
-74.70
1
A
A
THR
ASP
12
13
-143.64
1
B
B
C
N
ARG
ASP
78
79
0.72
1
C
C
C
N
ACE
PHE
0
1
2.46
1
D
D
C
N
ACE
PHE
0
1
3.21
1
-52.75
2.20
117.20
64.45
A
A
A
CA
C
N
ARG
ARG
ASP
78
78
79
Y
1
13.71
1.60
122.70
136.41
A
A
A
O
C
N
ARG
ARG
ASP
78
78
79
Y
1
-29.73
2.50
121.70
91.97
A
A
A
C
N
CA
ARG
ASP
ASP
78
79
79
Y
1
-30.34
2.20
117.20
86.86
B
B
B
CA
C
N
ARG
ARG
ASP
78
78
79
Y
1
-74.30
1.60
122.70
48.40
B
B
B
O
C
N
ARG
ARG
ASP
78
78
79
Y
1
-44.27
2.50
121.70
77.43
B
B
B
C
N
CA
ARG
ASP
ASP
78
79
79
Y
1
B
B
C
N
ARG
ASP
78
79
-0.617
0.023
1.336
0.719
Y
1
A
GLU
6
-133.43
-59.07
1
A
GLU
7
-138.90
-53.60
1
A
PRO
17
-30.39
130.28
1
A
GLU
60
59.93
-142.21
1
A
ARG
65
-160.24
117.08
1
B
GLU
60
58.30
-140.28
1
C
AIB
17
-11.77
-65.61
1
D
AIB
17
-11.32
-66.62
40.516
-0.82
0.00
-1.60
5.20
0.00
-4.27
0.903
0.855
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES WITH TLS ADDED
0.26207
0.22664
0.22830
2.48
42.35
514
10318
4.7
92.45
17.820
0.196
RANDOM
1
THROUGHOUT
OTHER
0.367
0.265
0.80
0.80
1.20
NONE
MAXIMUM LIKELIHOOD
MASK
2.48
42.35
72
1591
12
0
1507
0.010
0.019
1536
0.002
0.020
1446
1.845
1.968
2051
2.126
3.007
3326
7.916
5.000
177
32.874
23.951
81
18.411
15.000
279
16.301
15.000
10
0.523
0.200
204
0.005
0.021
1709
0.004
0.020
375
1
A
1
3439
X-RAY DIFFRACTION
interatomic distance
0.09
0.05
2
B
1
3439
X-RAY DIFFRACTION
interatomic distance
0.09
0.05
1
C
2
959
X-RAY DIFFRACTION
interatomic distance
0.14
0.05
2
D
2
959
X-RAY DIFFRACTION
interatomic distance
0.14
0.05
0.329
0.305
2.546
29
692
20
86.04
2.45
20.00
4BQD
12168
2.0
0.12
1
2.5
100.0
refinement
REFMAC
5.7.0029
TISSUE FACTOR PATHWAY INHIBITOR (LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR) VARIANT, PEPTIDE
KD1 of human TFPI in complex with a synthetic peptide
1
N
N
1
N
N
2
N
N
2
N
N
3
N
N
3
N
N
4
N
N
4
N
N
4
N
N
4
N
N
A
HIS
23
A
HIS
23
HELX_P
A
PHE
28
A
PHE
28
5
1
6
A
SER
68
A
SER
68
HELX_P
A
THR
77
A
THR
77
1
2
10
B
HIS
23
B
HIS
23
HELX_P
B
PHE
28
B
PHE
28
5
3
6
B
SER
68
B
SER
68
HELX_P
B
THR
77
B
THR
77
1
4
10
C
GLY
11
C
GLY
12
HELX_P
C
LEU
20
C
LEU
21
1
5
10
D
GLY
11
D
GLY
12
HELX_P
D
LEU
20
D
LEU
21
1
6
10
disulf
2.043
A
CYS
26
A
SG
CYS
26
1_555
A
CYS
76
A
SG
CYS
76
1_555
disulf
2.075
A
CYS
35
A
SG
CYS
35
1_555
A
CYS
59
A
SG
CYS
59
1_555
disulf
2.067
A
CYS
51
A
SG
CYS
51
1_555
A
CYS
72
A
SG
CYS
72
1_555
disulf
2.059
B
CYS
26
B
SG
CYS
26
1_555
B
CYS
76
B
SG
CYS
76
1_555
disulf
2.060
B
CYS
35
B
SG
CYS
35
1_555
B
CYS
59
B
SG
CYS
59
1_555
disulf
2.058
B
CYS
51
B
SG
CYS
51
1_555
B
CYS
72
B
SG
CYS
72
1_555
covale
1.330
both
C
LEU
16
C
C
LEU
17
1_555
C
AIB
17
C
N
AIB
18
1_555
covale
1.327
both
C
AIB
17
C
C
AIB
18
1_555
C
ALA
18
C
N
ALA
19
1_555
covale
1.330
both
D
LEU
16
D
C
LEU
17
1_555
D
AIB
17
D
N
AIB
18
1_555
covale
1.324
both
D
AIB
17
D
C
AIB
18
1_555
D
ALA
18
D
N
ALA
19
1_555
BLOOD CLOTTING
BLOOD CLOTTING
A
B
C
D
A
15
A
78
0
B
15
B
78
0
C
1
C
20
0
D
1
D
20
0
Q59EE5_HUMAN
UNP
1
Q59EE5
4BQD
PDB
2
4BQD
40
118
4BQD
1
79
Q59EE5
A
1
1
79
40
118
4BQD
1
79
Q59EE5
B
1
1
79
0
20
4BQD
0
20
4BQD
C
2
1
21
0
20
4BQD
0
20
4BQD
D
2
1
21
3
2
2
anti-parallel
parallel
anti-parallel
anti-parallel
A
THR
9
A
THR
9
A
ILE
11
A
ILE
11
A
GLU
3
A
GLU
3
A
ASP
5
A
ASP
5
A
LEU
19
A
LEU
19
A
LYS
20
A
LYS
20
A
MET
39
A
MET
39
A
ASN
45
A
ASN
45
A
GLN
50
A
GLN
50
A
TYR
56
A
TYR
56
B
MET
39
B
MET
39
B
ASN
45
B
ASN
45
B
GLN
50
B
GLN
50
B
TYR
56
B
TYR
56
BINDING SITE FOR RESIDUE GOL B 1080
Software
5
BINDING SITE FOR RESIDUE GOL B 1081
Software
4
B
ASP
31
B
ASP
31
5
1_555
B
GLY
33
B
GLY
33
5
1_555
B
PRO
34
B
PRO
34
5
1_555
B
HOH
2025
H
HOH
5
1_555
D
ARG
15
D
ARG
16
5
1_555
A
MET
39
A
MET
39
4
1_555
C
AIB
17
C
AIB
18
4
2_556
C
LEU
20
C
LEU
21
4
2_556
D
LEU
20
D
LEU
21
4
1_555
5
C 1 2 1